A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: Results of NRG Oncology RTOG 0913

Minesh Mehta

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: Results of NRG Oncology RTOG 0913

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	20
State	Published - Apr 9 2018

Access to Document

ViewcontentFinal published version, 20.4 KBLicense: Unspecified

Cite this

@article{92a3ddd7995a45c5816021da896b6293,

title = "A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: Results of NRG Oncology RTOG 0913",

author = "Minesh Mehta",

note = "Neuro-Oncology (2018) 20(5):666-673",

year = "2018",

month = apr,

day = "9",

language = "American English",

volume = "20",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: Results of NRG Oncology RTOG 0913

AU - Mehta, Minesh

N1 - Neuro-Oncology (2018) 20(5):666-673

PY - 2018/4/9

Y1 - 2018/4/9

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/2490

M3 - Article

VL - 20

JO - Neuro-oncology

JF - Neuro-oncology

ER -

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: Results of NRG Oncology RTOG 0913

Access to Document

Other files and links

Cite this